TY - JOUR
T1 - Mechanisms of immature myocardial tolerance to ischemia
T2 - Phenotypic differences in antioxidants, stress proteins, and oxidases
AU - Rowland, Robert T.
AU - Meng, Xianzhong
AU - Ao, Lihua
AU - Terada, Lance S.
AU - Harken, Alden H.
AU - Brown, James M.
N1 - Funding Information:
THE TOLERANCE TO ischemia/reperfusion injury differs between immature and mature myocardium. Newborn myocardium exhibits greater tolerance to periods of hypoxia than adult myocardium. 1,2 The immature heart also appears to be relatively resistant to periods of prolonged hypothermic ischemia 3, 4 or normothermic ischemia 4-6 when compared with the mature heart. De- Supported in part by National Institutes of Health grants HL44186, GM49222, and GM08315A. Presented at the Fifty-sixthA nnual Meeting of the Society of University Surgeons, Denver, Colo., Feb. 9-11, 1995. Reprint requests: Robert T. Rowland, MD, Department of Surgery, Universityo f Colorado Health Sciences Center, 4200 E. Ninth Ave. (C305), Denver, CO 80262. Copyright 9 1995 by Mosby-YearB ook, Inc. 0039-6060/95/$3.00 + 0 11/6/65014 spite evidence of improved cardiac tolerance, some studies have shown increased susceptibility to ischemia/ reperfusion injury in the newborn heart. 7, 8 The reasons for these age-related differences to hypoxic or ischemic injury are not well defined and have mainly been attributed to greater glycolytic capacity 1 and preservation of high-energy phosphates in the newborn heart. 2, 9 However, these differences may be further related to different oxidant-antioxidant balances or heat shock protein (HSP) expression between immature and mature myocardium. Myocardial tissue damage develops during re-oxygenation after an ischemic period, implicating oxygen radicals as important mediators of reperfusion injury. 1~ Xanthine oxidase (XO)--derived oxygen radicals participate in the damage observed during reperfusion of ischemic tissues in the isolated adult rat heartJ 1 Furthermore, increases in myocyte antioxidant enzyme ac-
PY - 1995/8
Y1 - 1995/8
N2 - Background. Previous work has suggested tolerance to ischemic injury in newborn myocardium. Although various mechanisms for this protection have been proposed, a link between oxidant-antioxidant factors, stress protein expression, and protection from cardiac ischemia/reperfusion (I/R) injury has not been made in newborn myocardium. We hypothesized that newborn myocardial resistance to I/R is related to decreased oxygen radical producing potential, increased free radical scavenging capacity and augmented stress protein expression. The purposes of the study were to examine in newborn and adult rat hearts (1) functional recovery from I/R, (2) catalase and xanthine oxidase (XO) activities, and (3) heat shock protein 72 (HSP 72) expression. Methods. Isolated rat hearts (7 to 10 days versus 60 days) were perfused on a noworking Langendorff apparatus at 60 mm Hg (Krebs-Henseleit buffer, pH 7.4, 37°C) and subjected to 20 minutes of global ischemia and 40 minutes of reperfusion. Left ventricular developed pressure was recorded by using a left ventricular catheter. Catalase and XO were measured by means of standard assays, and HSP 72 was assessed with in situ immunohistochemistry. Results. Newborn rat hearts had greater percentage functional recovery of left ventricular developed pressure after I/R (66.0%±4.2% versus 44.3%±3.5%; p<0.05). The newborn myocardium also had increased catalase activity (1027.9±20.6 units/gm versus 707.3±38.7 units/gm; p<0.05), whereas the activity of XO was decreased relative to the adult (0.23+0.01mU/gm versus 7.6+1.4 mU/gm; p<0.05). Furthermore, the expression of HSP 72 was greater in the newborn than the adult control. Conclusions. Relative to adult hearts, newborn rat hearts are more tolerant to a global ischemic insult followed by reperfusion. This improved functional recovery is associated with decreased oxidant production potential (XO), increased scavenging capacity (catalase), and augmented stress protein expression (HSP 72).
AB - Background. Previous work has suggested tolerance to ischemic injury in newborn myocardium. Although various mechanisms for this protection have been proposed, a link between oxidant-antioxidant factors, stress protein expression, and protection from cardiac ischemia/reperfusion (I/R) injury has not been made in newborn myocardium. We hypothesized that newborn myocardial resistance to I/R is related to decreased oxygen radical producing potential, increased free radical scavenging capacity and augmented stress protein expression. The purposes of the study were to examine in newborn and adult rat hearts (1) functional recovery from I/R, (2) catalase and xanthine oxidase (XO) activities, and (3) heat shock protein 72 (HSP 72) expression. Methods. Isolated rat hearts (7 to 10 days versus 60 days) were perfused on a noworking Langendorff apparatus at 60 mm Hg (Krebs-Henseleit buffer, pH 7.4, 37°C) and subjected to 20 minutes of global ischemia and 40 minutes of reperfusion. Left ventricular developed pressure was recorded by using a left ventricular catheter. Catalase and XO were measured by means of standard assays, and HSP 72 was assessed with in situ immunohistochemistry. Results. Newborn rat hearts had greater percentage functional recovery of left ventricular developed pressure after I/R (66.0%±4.2% versus 44.3%±3.5%; p<0.05). The newborn myocardium also had increased catalase activity (1027.9±20.6 units/gm versus 707.3±38.7 units/gm; p<0.05), whereas the activity of XO was decreased relative to the adult (0.23+0.01mU/gm versus 7.6+1.4 mU/gm; p<0.05). Furthermore, the expression of HSP 72 was greater in the newborn than the adult control. Conclusions. Relative to adult hearts, newborn rat hearts are more tolerant to a global ischemic insult followed by reperfusion. This improved functional recovery is associated with decreased oxidant production potential (XO), increased scavenging capacity (catalase), and augmented stress protein expression (HSP 72).
UR - http://www.scopus.com/inward/record.url?scp=0029127831&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029127831&partnerID=8YFLogxK
U2 - 10.1016/S0039-6060(05)80357-5
DO - 10.1016/S0039-6060(05)80357-5
M3 - Article
C2 - 7638763
AN - SCOPUS:0029127831
SN - 0039-6060
VL - 118
SP - 446
EP - 452
JO - Surgery (United States)
JF - Surgery (United States)
IS - 2
ER -